ACXP

ACXP

USD

Acurx Pharmaceuticals Inc. Common Stock

$4.730-0.020 (-0.421%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$4.750

High

$4.912

Low

$4.510

Volume

0.08M

Company Fundamentals

Market Cap

9.8M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.58M

Exchange

NCM

Currency

USD

52-Week Range

Low $3.8Current $4.730High $37.8

Related News

PR Newswire

Acurx Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 12, 2025 Conference Call and Provide Business Update

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics...

View more
Acurx Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 12, 2025 Conference Call and Provide Business Update
PR Newswire

Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small...

View more
Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors